Saeid Shahrabi

1.1k total citations
49 papers, 872 citations indexed

About

Saeid Shahrabi is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Saeid Shahrabi has authored 49 papers receiving a total of 872 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 19 papers in Molecular Biology and 18 papers in Genetics. Recurrent topics in Saeid Shahrabi's work include Acute Myeloid Leukemia Research (15 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers). Saeid Shahrabi is often cited by papers focused on Acute Myeloid Leukemia Research (15 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers). Saeid Shahrabi collaborates with scholars based in Iran, Netherlands and Italy. Saeid Shahrabi's co-authors include Najmaldin Saki, Mohammad Shahjahani, Ahmad Ahmadzadeh, Hadi Rezaeeyan, Ali Amin Asnafi, Habib Haybar, Zeinab Deris Zayeri, Seyed Mohammad Sadegh Pezeshki, Shirin Azizidoost and Habib Haybar and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cellular and Molecular Life Sciences and Journal of Cellular Physiology.

In The Last Decade

Saeid Shahrabi

47 papers receiving 859 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Saeid Shahrabi Iran 17 323 273 212 156 155 49 872
Nisha Nanda United States 14 286 0.9× 444 1.6× 213 1.0× 235 1.5× 101 0.7× 33 1.4k
Sujun Gao China 18 357 1.1× 427 1.6× 283 1.3× 217 1.4× 76 0.5× 96 1.0k
Jinsong Yan China 14 445 1.4× 249 0.9× 86 0.4× 77 0.5× 218 1.4× 66 787
Haifeng Zhao China 19 358 1.1× 236 0.9× 85 0.4× 172 1.1× 253 1.6× 83 1.0k
Giuseppa Penna Italy 16 499 1.5× 214 0.8× 126 0.6× 253 1.6× 265 1.7× 31 904
Kaavya Paruchuri United States 9 476 1.5× 189 0.7× 159 0.8× 79 0.5× 177 1.1× 20 1.2k
Laura Cicconi Italy 18 662 2.0× 432 1.6× 85 0.4× 118 0.8× 99 0.6× 32 918
Hui Shi China 18 296 0.9× 123 0.5× 98 0.5× 130 0.8× 83 0.5× 48 798
Tingliang Shen United States 9 475 1.5× 214 0.8× 97 0.5× 83 0.5× 260 1.7× 18 1.1k
Stefan Zöllner Germany 13 244 0.8× 192 0.7× 169 0.8× 116 0.7× 49 0.3× 26 811

Countries citing papers authored by Saeid Shahrabi

Since Specialization
Citations

This map shows the geographic impact of Saeid Shahrabi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saeid Shahrabi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saeid Shahrabi more than expected).

Fields of papers citing papers by Saeid Shahrabi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saeid Shahrabi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saeid Shahrabi. The network helps show where Saeid Shahrabi may publish in the future.

Co-authorship network of co-authors of Saeid Shahrabi

This figure shows the co-authorship network connecting the top 25 collaborators of Saeid Shahrabi. A scholar is included among the top collaborators of Saeid Shahrabi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saeid Shahrabi. Saeid Shahrabi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shahrabi, Saeid, et al.. (2023). Effect of Convalescent Plasma Therapy on COVID-19 Patients: A Retrospective Study. Jundishapur Journal of Chronic Disease Care. 12(1).
2.
Shahrabi, Saeid, et al.. (2020). Essential thrombocythemia: a hemostatic view of thrombogenic risk factors and prognosis. Molecular Biology Reports. 47(6). 4767–4778. 7 indexed citations
3.
Pezeshki, Seyed Mohammad Sadegh, et al.. (2020). Co-existence of mutations in myeloproliferative neoplasms and their clinical significance: a prognostic approach. Expert Review of Hematology. 13(11). 1289–1301. 2 indexed citations
4.
Shahrabi, Saeid, et al.. (2020). T-Cell Molecular Modulation Responses in Atherosclerosis Anergy. Laboratory Medicine. 51(6). 557–565. 2 indexed citations
5.
Shahrabi, Saeid, et al.. (2019). Neutropenia and leukemia development: genetic risk factors and prognosis. Leukemia & lymphoma. 60(14). 3363–3374. 11 indexed citations
6.
Haybar, Habib, et al.. (2019). Strategies to inhibit arsenic trioxide‐induced cardiotoxicity in acute promyelocytic leukemia. Journal of Cellular Physiology. 234(9). 14500–14506. 30 indexed citations
7.
Shahjahani, Mohammad, et al.. (2019). Complex karyotype in myelodysplastic syndromes: Diagnostic procedure and prognostic susceptibility. Oncology Reviews. 13(1). 389–389. 11 indexed citations
8.
Samimi, Azin, et al.. (2019). Role of bone marrow adipocytes in leukemia and chemotherapy challenges. Cellular and Molecular Life Sciences. 76(13). 2489–2497. 24 indexed citations
9.
Shahrabi, Saeid, et al.. (2018). Aberrant DNA Methylation in Chronic Myeloid Leukemia: Cell Fate Control, Prognosis, and Therapeutic Response. Biochemical Genetics. 56(3). 149–175. 14 indexed citations
10.
Haybar, Habib, Saeid Shahrabi, Zeinab Deris Zayeri, & Seyed Mohammad Sadegh Pezeshki. (2018). Strategies to increase cardioprotection through cardioprotective chemokines in chemotherapy-induced cardiotoxicity. International Journal of Cardiology. 269. 276–282. 25 indexed citations
11.
Shahjahani, Mohammad, et al.. (2017). MicroRNAs as prognostic biomarker and relapse indicator in leukemia. Clinical & Translational Oncology. 19(8). 951–960. 9 indexed citations
12.
Khodadi, Elahe, et al.. (2016). Role of stem cell factor in the placental niche. Cell and Tissue Research. 366(3). 523–531. 27 indexed citations
13.
Shahrabi, Saeid, et al.. (2016). Regulatory role of Megakaryocytes on Hematopoietic Stem Cells Quiescence by CXCL4/PF4 in Bone Marrow Niche. Leukemia Research. 48. 107–112. 14 indexed citations
14.
Shahrabi, Saeid, et al.. (2015). The bone marrow metastasis niche in retinoblastoma. Cellular Oncology. 38(4). 253–263. 14 indexed citations
15.
Ahmadzadeh, Ahmad, et al.. (2015). Wnt/β-catenin signaling in bone marrow niche. Cell and Tissue Research. 363(2). 321–335. 62 indexed citations
16.
Ahmadzadeh, Ahmad, Richard E. Kast, Saeid Shahrabi, et al.. (2015). Regulatory effect of chemokines in bone marrow niche. Cell and Tissue Research. 361(2). 401–410. 14 indexed citations
17.
Ahmadzadeh, Ahmad, et al.. (2015). Twist as a new prognostic marker in hematological malignancies. Clinical & Translational Oncology. 18(2). 113–124. 22 indexed citations
18.
Shahrabi, Saeid, Shirin Azizidoost, Mohammad Shahjahani, et al.. (2014). New insights in cellular and molecular aspects of BM niche in chronic myelogenous leukemia. Tumor Biology. 35(11). 10627–10633. 18 indexed citations
19.
Shahjahani, Mohammad, et al.. (2014). The role of Pax5 in leukemia: diagnosis and prognosis significance. Medical Oncology. 32(1). 360–360. 18 indexed citations
20.
Shahrabi, Saeid, et al.. (2005). Distribution of estrogen and progesterone receptors in Epulis Fissuratum. 18(243). 59–66.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026